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Crystallization of Prostaglandin-H Synthase
for X-Ray Structure Analysis
by Karin Jahnke,* Gisela H. Degen,t and Manfred Buehner*
Prostaglandin-H (PGH) synthase from ram seminal vesicles is a dimeric integral membrane protein of
molecular weight 140 kDa. PGH synthase is a key enzyme in the biosynthesis of prostaglandins, has
cyclooxygenase and peroxidase activities, and contains heme as a coenzyme. In the peroxidation step of
its reaction, PGH synthase can use xenobiotics as co-substrates and can catalyze the metabolic activation
ofcarcinogens such as diethylstilbestrol. To gain a detailed understanding ofthe inner workings ofPGH
synthase, we are investigating its three-dimensional structure by X-ray crystallography. A purification
procedure was established that yields stable homogeneous PGH synthase that is at least 80o holoenzyme.
The crucial aspect is the proper choice oftype and concentration ofdetergent in all steps ofthe procedure.
Single crystals can be obtained from concentrated solutions of PGH synthase in the presence of polyeth-
yleneglycol4000 as aprecipitant. Crystallization occursduringgasphaseequilibrationwithaconcentrated
salt solution. The enzyme solution becomes turbid and forms a second liquid phase in which PGH synthase
crystals grow up to 0.2 mm in length in the course ofdays. Manipulation ofthese crystals is very difficult
due to the small volume of the growth phase. The crystals dissolved rapidly in all aqueous media into
which they were transferred for mounting in X-ray capillaries. Therefore, we have not yet been able to
demonstrate their true X-ray scattering power. A crystal provisionally dry mounted diffracted to about 8
A resolution.
Introduction
Prostaglandin-H (PGH) synthase is an enzyme that
holds a key position in the biosynthesis of prostaglan-
dins. Prostaglandins are mediators of many physiolog-
ical and pathophysiological processes such as inflam-
mation. The importance of PGH synthase-dependent
reactions isunderlined bythe factthat manydrugshave
been developed that are inhibitors of PGH synthase
(e.g., aspirin).
PGH synthase has cyclooxygenase and peroxidase ac-
tivities and contains heme as a coenzyme. In the per-
oxidation step ofits reaction, PGH synthase can oxidize
endogenous compounds as well as xenobiotics as co-
substrates. PGH synthase thus is assumed toplay arole
similar to that of cytochrome P-450 in the metabolic
activation ofcarcinogens (e.g., diethylstilbestrol). More
information about the metabolic role of PGH synthase
and its reactions is given by Marnett (1).
To gain a better understanding (and possibly control)
of the inner workings of PGH synthase, we are inves-
tigating its spatial structure by X-ray crystallography.
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The final goal of this project is to lay the structural
foundation for molecular modeling, for developing bet-
ter drugs, and, possibly, for developing inhibitors of
unwanted reactions of PGH synthase. Three-dimen-
sional structure determination of membrane proteins
has come within reach in recent years with the availa-
bility of new nonionic detergents which allow for im-
proved protein purification and crystallization (2,3).
Properties of PGH Synthase
Enzyme isolated from ram seminal vesicles is the
PGH synthase species most widely investigated due to
its relatively good yield and reasonably uncomplicated
purification. PGH synthase is an integral membrane
protein, ahomodimer ofmolecularweight 140 kDa. The
enzymecontains3.5%carbohydrate ofthehighmannose
type (4). The amino acid sequence ofPGH synthase has
been determined from its cDNA sequence (5-7). The
open reading frame codes for 600 amino acids; the N-
terminal 24 represent a signal peptide, while the C-
terminal 576 constitute the mature protein (Fig. 1).
Serin506 is part ofthe active center ofPGH synthase;
it is acetylated by the inhibitor aspirin (8). Rather than
showing a distinct pattern offatty patches, transmem-
brane spanning stretches ofpurely hydrophobic amino
acids that would be expected of an integral membrane
protein, the mature protein contains only one long se-
quence of continuously high hydrophobicity, Val267-
Leu282 (Fig. 2). It is proposed that the protein consistsJAHNKE, DEGEN, AND BUEHNER
- 24
Signal peptide:
Mature en;
A D P
S G P
A T F
V S Y
R K F
G H G
S V E
W L R
I E E
Y H W
A F S
E Y R
P G L
W K A
P R Q
M S R Q S I S L R F P L L L L L L S P S P V F S
zyme:
G AP A P V N P C C Y Y P C Q H Q G I C V R F G L D R Y Q C D C T R T GY
NC T I PEI W T W L R T T L RP S PS F I H F LbT H G RW L WD F V N
I RD T L MR L V L T V R S N L I P S P PT Y N I A H D Y I S WE S F S N
Y TR I L P SV P R D CP T P MG T KG K K QL P D A EF L S RR F L L R
I PD P Q G TN L M F A F F AQ H FT H Q F F K T S G KM G PG F T K A L
V DL G H I YG D N L ER Q Y QL R LF K D GK L K Y QM L N GE V Y P P
E AP V L M HY P R G I PP Q SQ M AV G Q EV F G L LP G L ML Y A T I
E H N R V C DL L K A E H P T WG D EQ L F Q T A R L I L I G ET I K I V
Y V Q Q L S G Y F L Q L K F D P E L L F G A Q F Q Y R N R I AM E F N Q L
H PL M P D SF R V G PQ D Y SY E QF L F NT S M L VD Y G VE A L V D
R QP A G R IG G G R N I D HH I L HV A V DV I K E SR V L RL Q P F N
K RF G M K PY T S F QE L T GE K EM A A EL E E L YG D I DA L E F Y
L LE K C H PN S I F GE S M IE M GA P F SL K G L LG N P IC S P E Y
S TF G G E VG F N L VK T A TL K KL V C LN T K T CP Y V SF H V P D
E DR P G VE R P P T EL
Asn4, Asn'0, Asn120, Asn350: possible glycosylation sites
Val267-Leu"2: possible transmembrane segment
Ser": aspirin acetylation site
FIGURE 1. Amino acid sequence of ram PGH synthase. From Yokoyama et al. (7).
3.0
2.0
1. 0
.0
- 1. 0
-2. 0
-3. 0
Prostcglondin-H Synthase
PHS N = 600 WINDOW = 5
D
0 100 200 300 400 500 600
RESIDUE NR.
FIGURE 2. Hydropathy plot of the full polypeptide chain of PGH
synthase. The signal peptide is separated from the mature protein
at residue 24 (shown by a vertical line); the likely transmembrane
domain link is marked by an arrow. Coefficients according to Kyte
and Doolittle (9) and local FORTRAN program HYPLOT.
ofessentially two independent domains (6), soluble pro-
teinincharacter, located oneitherside ofthemembrane
and connected by a single hydrophobic spacer in ex-
tended conformation.
Critical Features of PGH Synthase
Purification
In dealing with a membrane protein, the crucial as-
pectduringall steps andprocedures isthe properchoice
of type and concentration of detergent. The detergent
has to solubilize the enzyme from the membrane and
keep it in solution afterwards, but it should not damage
it. For PGH synthase, the commonly used solubilizing
detergentisTween20. Weencountered, however, some
problems with this detergent: Tween 20 is often con-
taminatedbyperoxidescapableofdamagingtheenzyme
protein, and it cannot easilybe removed by dialysis and
is even concentrated by ultrafiltration due to its low
critical micelle concentration, which makes the deter-
gent behave like a macromolecule.
In our laboratory, Tween 20 promoted dissociation of
the dimeric enzyme into monomers, loss of coenzyme,
and adeclineofenzymaticactivity(10). Heme-free PGH
synthase is less stable and has been found to be readily
cleaved by trypsin (11). The apoenzyme can be recon-
stituted to afunctional state by addition ofhematin; the
stoichiometry of heme binding (0.5 or 1.0 heme mole-
cules per subunit) is still a matter of controversy.
Garavito and co-workers reported crystals obtained
from Tween 20-purified PGH synthase that was recon-
stituted by addition of heme (personal communication;
12). However, these crystals were severely disordered
and did not diffract to high resolution (Garavito, per-
sonalcommunication). Therefore, to avoid the problems
inreconstituting aholo-dimerfrompartlydamagedapo-
mnonomers, we chose a different approach with the ob-
jective ofpurifying the intact holoenzyme.
A purification procedure for PGH synthase is now
established that reproducibly yields a stable homoge-
neous dimeric product that is at least 80% holoenzyme.
For solubilization and during purification, the best
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Table 1. Purification of ram PGH synthase.a
Total unitsb Protein, mgc U/mg Relative yield, %
Microsomes 605,848 186.3 3,252 100.0
Solubilizate 856,818 81.0 10,578 141.4
DEAE-filtrate 344,545 71.9 4,792 56.9
DEAE-chromatography 243,898 7.8 31,269 40.3
Gel-filtration 234,971 6.3 37,297 38.8
Reconstituted (heme) 243,552d 38,659d
aPGH synthase from 22 g of tissue.
bEnzyme activities are calculated from initial rates of oxygen consumption measured upon addition of 70 ,uM arachidonic acid to an incubation
ofPGH synthase in buffer containing 1.0 mM adrenalin according to Kulmacz and Lands (13). Enzyme units are nmole 02/min.
'Protein concentration wasdetermined by the method of Bradford (14) with a Bio-Rad Assay Kit using -y-globulin standard.
dHematin, 1 puM, added to assay incubation mixture described in footnote b.
detergent was N,N-dimethyl-decylamine-N-oxide
(DDAO), which replaces Tween 20. For details see
Jahnke etal. (10). Anexample ofanenzyme preparation
is shown in Table 1.
The apparent increase in enzyme activity upon solu-
bilization ofPGHsynthase frommicrosomalmembranes
is reproducible. The yield ofenzyme protein in the sub-
sequent steps compares favorably with published pro-
cedures. This yield can be attributed to an optimized
purification scheme and tothe high quality ofthe (fresh)
tissue: As found byimmunoblot analysis, PGH synthase
represents more than 10% of the microsomal protein
fromram seminal vesicles (G. H. Degen and B. Fischer,
unpublished). The final fraction yields a single homo-
geneous band in silver-stained gels of both native and
SDS-PAGE (data not shown).
Preparations different from the one shown in Table
1, when assayed for activity both in the absence and
presence of hematin over a period of days and weeks,
indicate the presence ofprobablythreedifferent species
of PGH synthase molecules: a) native holo-PGH syn-
thase that is rather stable (enzymatic activity assayed
without hematin addition); b) native apo-PGH synthase
that is initially reconstitutable (determined by an in-
crease in enzymatic activity upon addition of hematin)
and which, however, degrades with time to c) damaged
PGH synthase. The last species can no longer be re-
constituted byheme additionandgivesrise toadditional
bands in SDS gels.
Attention is drawn to the capacity for reconstitution
since it may affect the potential ofagiven enzyme prep-
aration for crystallization in general and the quality of
the crystals in particular. PGH synthase can usually be
crystallized if the fraction ofholoenzyme exceeds 75%.
The presence ofa limited amount ofapoenzyme is a less
seriousproblemthantheprocessofreconstitutionitself.
We have been able to grow crystals from PGH synthase
preparations that contained heme-reconstituted en-
zyme. These crystals were highly disordered, became
insoluble after some days (this effect was also reported
by M. Garavito, personal communication) and did not
diffract X-rays.
Crystallization
Crystallization of holo-PGH synthase is possible in
the presence ofthe detergent octyl-3-glucoside. Single
crystals of native holo-PGH synthase can be obtained
from concentrated (> 5 mg/mL) solutions of(nonrecon-
stituted) enzyme in the presence ofpolyethylene glycol
(PEG) 4000 as a precipitating agent. The enzyme so-
lution is equilibrated through the gas phase (hanging or
sitting drop method) with a concentrated salt solution.
The enzyme solution concentrated in this way be-
comesturbid, andmixedmicellesareformedthatslowly
coalesce into asecond liquid phase. Inthis phase brown-
ish PGH synthase crystals grow up to 0.2 mm in length
and up to 0.1 mm in width within a few days. A typical
crystallization experiment might be started from a so-
lution containing 7mg/mL holo-PGH synthase and 3.0%
PEG 4000 equilibrated with 2.0 M ammonium sulfate
(increased stepwise from 1.4 M).
PGH synthase crystals are often in the shape of
square prisms. They have sharp edges and faces and
display good extinction under polarized light. Unfor-
tunately, their manipulation is very difficult due to the
extremely small volume of the growth phase. So far,
we have not been able to demonstrate the true X-ray
scattering power of the crystals, because all crystals
dissolved rapidly in any aqueous medium into which
theyweretransferred formountinginX-raycapillaries.
At present we are attempting to simulate as closely
as possible the second liquid phase in which the crystals
grow. The major problem is that the contribution of
solute PGH synthase in the solid/solute equilibrium has
tobemimickedbysubstances which areinbettersupply
than PGH synthase itselfand yet do not interfere with
the crystals.
Nevertheless, we have ventured to mount a crystal
dry, accepting a very high risk of damage and fast de-
cay. The dry-mounted crystal displayed reflections out
to a resolution limit of about 8 A in a still photograph.
The crystallographic space group could not be deter-
mined with the rapidly decaying dry crystal. We are
confident that crystals properly mounted in a suitable
mother liquor environment will give better results.
NOTE ADDED IN PROOF: The crystallographic space
group ofthe crystals could recently be determined as I
422 with cell constants a = 142A and c = 172A. There
is one protein subunit in the crystallographic asym-
metric unit. Therefore, in the crystalline state, the di-
meric molecule is fully symmetrical.
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